Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 407,407 | -1,189,957 | 475,690 | 527,854 | 262,704 |
| Depreciation Amortization | 11,671 | 47,284 | 35,517 | 23,833 | 11,243 |
| Income taxes - deferred | 7,848 | -9,220 | -271 | -13,344 | -626 |
| Accounts receivable | -74,836 | -184,370 | -177,570 | -82,961 | -41,329 |
| Accounts payable and accrued liabilities | -71,150 | 263,965 | 136,880 | 82,909 | -874 |
| Other Working Capital | -841 | -286,169 | 62,792 | -155,526 | -62,269 |
| Other Operating Activity | 210,394 | 2,576,526 | 205,513 | 105,028 | 53,045 |
| Operating Cash Flow | $490,493 | $1,218,059 | $738,551 | $487,793 | $221,894 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -565,390 | 1,110,698 | -1,039,014 | -824,893 | -675,736 |
| PPE Investments | -25,041 | -105,208 | -74,995 | -33,584 | -14,258 |
| Net Acquisitions | N/A | -2,736,172 | -356,167 | N/A | N/A |
| Purchase Of Investment | N/A | -8,652 | -31,688 | -56,244 | N/A |
| Investing Cash Flow | $-590,431 | $-1,739,334 | $-1,501,864 | $-914,721 | $-689,994 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,276,242 | 1,276,242 | 1,276,242 | N/A |
| Debt Repayment | -99,137 | -580,684 | -540,563 | -480,421 | -56,132 |
| Common Stock Issued | 83,586 | 403,386 | 359,319 | 313,399 | 43,529 |
| Common Stock Repurchased | N/A | -544,942 | -544,943 | -544,943 | N/A |
| Other Financing Activity | 33,770 | 95,259 | 79,779 | 50,499 | 37,380 |
| Financing Cash Flow | $18,219 | $649,261 | $629,834 | $614,776 | $24,777 |
| Exchange Rate Effect | -5,146 | -19,892 | -14,854 | -11,312 | 4,087 |
| Beginning Cash Position | 816,007 | 707,913 | 707,913 | 707,913 | 707,913 |
| End Cash Position | 729,142 | 816,007 | 559,580 | 884,449 | 268,677 |
| Net Cash Flow | $-86,865 | $108,094 | $-148,333 | $176,536 | $-439,236 |
| Free Cash Flow | |||||
| Operating Cash Flow | 490,493 | 1,218,059 | 738,551 | 487,793 | 221,894 |
| Capital Expenditure | -25,041 | -105,208 | -74,995 | -33,584 | -14,258 |
| Free Cash Flow | 465,452 | 1,112,851 | 663,556 | 454,209 | 207,636 |